09.01.2025 – 11:00Bosch Healthcare Solutions GmbHVivalytic Bacterial Meningitis by Bosch: PCR rapid test for medical emergenciesmehr
19.12.2024 – 11:43RHEACELL GmbH und Co. KGRHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcersmehr
11.12.2024 – 14:03Helmholtz MunichMaria-Elena Torres-Padilla Honored With the Leibniz Prize 2025Read Interviewmehr
28.11.2024 – 15:22GEA Group AktiengesellschaftGEA launches Body Condition Scoring for cowsVisit GEA's press websiteEin Dokumentmehr
25.11.2024 – 13:52Helmholtz MunichInceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapiesmehr
14.11.2024 – 14:00PNO Innovation GmbHLast Call for canSERV Third Open Call FundingOpen CallEin Dokumentmehr
16.10.2024 – 14:00PNO Innovation GmbHEvent Announcement: VIROFIGHT Hybrid SymposiumRegister HereEin Dokumentmehr
24.09.2024 – 12:25RHEACELL GmbH und Co. KGRHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVUmehr
17.09.2024 – 14:05PNO Innovation GmbHLaunch of canSERV Call for Service Provision – "Training the Next Generation of Cancer Researchers"Challenge CallEin Dokumentmehr
04.09.2024 – 15:13Fördergesellschaft IZB mbH2Record financing rounds at the Munich biotech hubFind out more about the 40+ biotech start-ups at the IZBEin Dokumentmehr
28.02.2024 – 15:00RHEACELL GmbH und Co. KGResearch Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘mehr
23.02.2024 – 10:28Leipzig Tourismus und Marketing GmbH5Pioneering Heart Surgery and Medical Congresses in LeipzigEin Dokumentmehr
16.11.2023 – 10:27Fruit Vegetables EuropeTen benefits of a daily intake of citrus fruits during winter seasonmehr
30.08.2023 – 12:28STADA Arzneimittel AG2Press release : People with Parkinson’s experience variations in effects of oral medicines, but lack advice, international survey revealsEin Dokumentmehr
27.06.2023 – 11:23RHEACELL GmbH und Co. KGRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affectedmehr
23.03.2023 – 12:04hubergroup Deutschland GmbH5Press Release - hubergroup India expands its support for rural healthcareMore about hubergroupEin Dokumentmehr
09.03.2023 – 10:00Medias Klinikum GmbH & Co KGThe world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remissionmehr
28.02.2023 – 07:30Fördergesellschaft IZB mbHInnovation and Start-up Center Biotechnology (IZB) welcomes InvitrisIn the IZB you can find over 50 biotech start-upsEin Dokumentmehr
08.02.2023 – 13:26BrainRepair UGBreakthrough - EUR 50 million investment for start-up BrainRepair UG / Pivotal trial on stem cell treatment for brain damage in newborns fully fundedmehr
09.11.2022 – 10:39RHEACELL GmbH und Co. KGStem cell therapy for “Butterfly disease” / RHEACELL receives ‘Partners in Progress Award’ from debra of America for Epidermolysis Bullosa researchmehr
20.10.2022 – 12:00Klinik für Prostata-Therapie HeidelbergFocal therapy for prostate cancer: Reliable diagnosis leads to gentle treatmentmehr
19.07.2022 – 08:00R-Biopharm AGR-Biopharm starts commercialization of the fully automated RIDA®UNITY system for real-time PCR in molecular diagnostic laboratoriesmehr
24.02.2022 – 16:41Fördergesellschaft IZB mbHInnovation and Start-Up Center for Biotechnology (IZB) welcomes new start-up Origin.BioIn the IZB you can find over 50 biotech start-upsEin Dokumentmehr
18.02.2022 – 11:15EcoCare2Exclusive Health & Safety Partner of the Munich Security Conference 2022: EcoCare commissioned to carry out daily COVID-19 tests on top politicians and diplomatsmehr
19.01.2022 – 12:51News DirectALDER HEY AND NEEDLESMART PARTNERSHIP AIMS TO REDUCE 100,000 NEEDLESTICK INJURIES TO NHS HEALTHCARE WORKERSmehr
07.12.2021 – 11:41R-Biopharm AG2R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislationmehr